680 related articles for article (PubMed ID: 26753752)
1. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Lymph Node Yield After Neoadjuvant Chemoradiation for Gastric Cancer.
Allen CJ; Vreeland TJ; Newhook TE; Das P; Minsky BD; Blum M; Ajani J; Ikoma N; Mansfield PF; Badgwell BD
Ann Surg Oncol; 2020 Feb; 27(2):534-542. PubMed ID: 31552618
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis.
Shridhar R; Dombi GW; Weber J; Hoffe SE; Meredith K; Konski A
Am J Clin Oncol; 2012 Jun; 35(3):216-21. PubMed ID: 21378540
[TBL] [Abstract][Full Text] [Related]
4. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
[TBL] [Abstract][Full Text] [Related]
5. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
6. The addition of chemoradiation to adjuvant chemotherapy is associated with improved survival in lymph node-positive gastric cancer.
Altman AM; Sheka AC; Marmor S; Lou E; Reynolds M; Hui JYC; Tuttle TM; Jensen EH; Denbo JW
Surg Oncol; 2020 Sep; 34():134-139. PubMed ID: 32891318
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors associated with survival in a large cohort of gastric cancer patients resected over a decade at a single Italian center: the Cremona experience.
Ghidini M; Donida BM; Totaro L; Ratti M; Pizzo C; Benzoni I; Lomiento D; Aldighieri F; Toppo L; Ranieri V; Senti C; Tanzi G; Martinotti M; Passalacqua R; Rovatti M; Tomasello G
Clin Transl Oncol; 2020 Jul; 22(7):1004-1012. PubMed ID: 31599376
[TBL] [Abstract][Full Text] [Related]
8. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
9. Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy.
Kim Y; Squires MH; Poultsides GA; Fields RC; Weber SM; Votanopoulos KI; Kooby DA; Worhunsky DJ; Jin LX; Hawkins WG; Acher AW; Cho CS; Saunders N; Levine EA; Schmidt CR; Maithel SK; Pawlik TM
Surgery; 2017 Aug; 162(2):285-294. PubMed ID: 28578142
[TBL] [Abstract][Full Text] [Related]
10. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.
Badgwell B; Blum M; Estrella J; Chiang YJ; Das P; Matamoros A; Fournier K; Mansfield P; Ajani J
J Am Coll Surg; 2015 Jul; 221(1):83-90. PubMed ID: 26002780
[TBL] [Abstract][Full Text] [Related]
12. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
[TBL] [Abstract][Full Text] [Related]
13. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG
Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823
[TBL] [Abstract][Full Text] [Related]
15. Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection.
Biffi R; Botteri E; Cenciarelli S; Luca F; Pozzi S; Valvo M; Sonzogni A; Chiappa A; Leal Ghezzi T; Rotmensz N; Bagnardi V; Andreoni B
Eur J Surg Oncol; 2011 Apr; 37(4):305-11. PubMed ID: 21288685
[TBL] [Abstract][Full Text] [Related]
16. Lymphadenectomy in patients with gastric cancer. A critical review.
Nitti D; Marchet A; Olivieri M; Ambrosi A; Mencarelli R; Farinati F; Belluco C; Lise M
Suppl Tumori; 2003; 2(5):S35-8. PubMed ID: 12914388
[TBL] [Abstract][Full Text] [Related]
17. Impact of Total Lymph Node Count on Staging and Survival After Neoadjuvant Chemoradiation Therapy for Rectal Cancer.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Kim J; Wong JY; Chen YJ
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S580-7. PubMed ID: 25956577
[TBL] [Abstract][Full Text] [Related]
18. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
[TBL] [Abstract][Full Text] [Related]
20. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.
Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ
Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]